Skip to main content
main-content

Vasculitis

Journal articles and book chapters

14-12-2018 | Pediatric | Article

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review

Jung JY et al. Pediatr Rheumatol 2018; 16: 79. doi: 10.1186/s12969-018-0296-z

20-11-2018 | Polymyalgia rheumatica | Article

Comorbidities in polymyalgia rheumatica: A systematic review

Partington R et al. Arthritis Res Ther 2018; 20: 258. doi: 10.1186/s13075-018-1757-y

01-10-2018 | Kawasaki disease | Article

Association of initially normal coronary arteries with normal findings on follow-up echocardiography in patients with Kawasaki disease

de Ferranti SD et al. JAMA Pediatr 2018: e183310. doi: 10.1001/jamapediatrics.2018.3310

27-09-2018 | Giant cell arteritis | Article

Full blood count as an ancillary test to support the diagnosis of giant cell arteritis

Oh LJ et al. Intern Med J 2018; 48: 408–413. doi: 10.1111/imj.13713

27-09-2018 | Small-vessel vasculitis | Article

Treatment of urticarial vasculitis: A systematic review

Kolkhir P et al. J Allergy Clin Immunol 2018. doi: 10.1016/j.jaci.2018.09.007

17-09-2018 | Large-vessel vasculitis | Review | Article

Diagnosis and differential diagnosis of large-vessel vasculitides

Keser G, Aksu K. Rheumatol Int 2018. doi: 10.1007/s00296-018-4157-3

31-08-2018 | Immune checkpoint inhibitor-induced rheumatic disease | Review | Article

Rheumatic immune-related adverse events from cancer immunotherapy

Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

29-08-2018 | Giant cell arteritis | Article

Additional costs of polymyalgia rheumatica with giant‐cell arteritis

Mounié M et al. Arthritis Care Res 2018. doi: 10.1002/acr.23736

14-08-2018 | ANCA-associated vasculitis | Review | Article

B cell therapy in ANCA-associated vasculitis: Current and emerging treatment options

McClure M et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0065-x

13-08-2018 | Behçet’s disease | Review | Article

Management of major organ involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations

Ozguler Y et al. Rheumatology (Oxford) 2018: key242. doi: 10.1093/rheumatology/key242

12-07-2018 | Takayasu arteritis | Article

Certolizumab pegol in the treatment of Takayasu arteritis

Novikov P et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key197

11-07-2018 | Takayasu arteritis | Article

Extravascular manifestations of Takayasu arteritis: Focusing on the features shared with spondyloarthritis

Kwon OC et al. Arthritis Res Ther 2018; 20: 142. doi: 10.1186/s13075-018-1643-7

09-07-2018 | Behçet’s disease | Article

Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: Subgroup analysis of data from the VENOST study

Uluduz D et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key153

07-07-2018 | Behçet’s disease | Article

Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet’s disease: Which and when to use?

Hammad M et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4194-z

03-07-2018 | Vasculitis | Article

Oral cyclophosphamide in treatment of patients with refractory idiopathic inflammatory myopathies: A retrospective observational study

Bae S, Charles-Schoeman C. Clin Rheumatol 2018; 37: 2113–2123. doi: 10.1007/s10067-018-4174-3

28-06-2018 | Giant cell arteritis | Article

Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis

Gloor AD et al. Rheumatology (Oxford) 2018: key158. doi: 10.1093/rheumatology/key158

21-06-2018 | Pathogenesis | Review | Article

The role of neutrophil extracellular traps in rheumatic diseases

Apel F, Zychlinsky A, Kenny EF. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0039-z

19-06-2018 | Vasculitis | Article

Vasculitis associated with immune checkpoint inhibitors: A systematic review

Daxini A, Cronin K, Sreih AG. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4177-0

image credits